Brief: Nykode Therapeutics Top Managers Resign
March 27 (Reuters) - Nykode Therapeutics ASA NYKD.OL: RESIGNATION OF CHAIR OF THE BOARD, BOARD MEMBERS, CHIEF EXECUTIVE OFFICER, CHIEF SCIENTIFIC OFFICER AND CHIEF FINANCIAL OFFICER BOARD WILL AS SOON AS POSSIBLE CALL FOR AN EXTRAORDINARY GENERAL MEETING TO ELECT A NEW BOARD Source text: ID:nObizGT5va Further company coverage: NYKD.OL (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Nykode Therapeutics ASA
See all newsRCS - Accession Theraptcs. - Accession Therapeutics: Board appointments
Brief: Nykode Therapeutics Mulls Private Placement
Brief: Nykode Receives Draft Recommendation In Tax Case
Brief: Nykode Therapeutics Receives U.S. Vaccine Patent
Brief: Nykode Therapeutics Expects Draft Recommendation From Norwegian Tax Appeal Board In August 2026